B2M and graft versus host disease: Further, TCRα constant (TRAC) or beta-2-microglobulin (B2M) gene knocked-out CD19-specific CAR T cells may markedly result in reduced GVHD development upon CAR T cell infusion into leukemic mouse models (Gao et al., 2019a).